Exo, a fibronasogastric pipeline imaging startup founded in 2015, is still in the hunt for investment. They’re said to be in negotiations with Samsung for a rumored $100 million round. The company has gained attention for its development of handheld medical imaging devices that leverage advanced technologies to enhance ultrasound examinations.
Exo focuses on creating portable devices that leverage artificial intelligence, medical imaging and silicon science. These cutting edge devices are able to be adapted for multiple uses from scanning lungs, echocardiograms and many more capabilities. The integration of these technologies allows medical examiners to conduct examinations more efficiently, document findings, and share reports seamlessly through a single mobile application.
With their prominence established, in 2021 Exo raised a whopping $220 million in a Series C funding round. This accomplishment firmly planted the seeds for its subsequent rapid expansion and maturation. So far, the firm has raised more than $320 million in total funding, drawing investment from a deep bench of high-profile investors. Notable backers include RA Capital Management, BlackRock, Sands Capital, Intel, Sony, and Avidity Partners, all of whom recognize the potential impact of Exo’s technology on the healthcare industry.
The handheld, portable tools that Exo has developed make them especially attractive for on-the-go medical professionals. Their small size makes it easy to integrate them into smartphones. This innovation brings ultrasound examinations to more patients, including those in remote or underserved areas. This increased portability requires unique considerations in order for medical examiners to deliver this immediate care, ultimately setting up the best patient outcomes.
As the healthcare landscape continues to evolve, the demand for innovative medical technologies like those developed by Exo is increasing. This is an incredibly exciting potential partnership for Exo to significantly bolster its capabilities and help expand its market reach. This unique collaboration provides tremendous prospects for expansion in the medical imaging field.
Leave a Reply